Loading...

Please wait

Podcast

Loading...

OndaCast© 2026 OndaCast. All rights reserved.

Help Contact Terms Privacy Copyright DMCA About Radio Guide Embed Player

Waves Explore Library Vibes Podcasts Audiobooks

Connected With Latham - Podcast | OndaCast

Podcast

Back to Podcasts

Connected With Latham

Podcast ShowPodcasten

Connected With Latham

ByLatham & Watkins

In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.

107 episodes•0 subscribers•0 Total Listens

Episode Playlist

50 episodes

Episode 58 – FDI Developments: M&A Security Screening in Europe's Fragmented FDI Landscape

Oct 24, 2023•—

Episode 58 – FDI Developments: M&A Security Screening in Europe's Fragmented FDI Landscape

Episode 59 – SCOTUS Update: Perez v. Sturgis Secures a Supreme Court Win for Disability Rights

Nov 2, 2023•—

Episode 59 – SCOTUS Update: Perez v. Sturgis Secures a Supreme Court Win for Disability Rights

Episode 60 – PE Views: Is the CMA's Focus on Roll-Up Transactions Here to Stay?

Nov 10, 2023•—

Episode 60 – PE Views: Is the CMA's Focus on Roll-Up Transactions Here to Stay?

Episode 61 – Drug Pricing: New OIG Guidance Reaffirms the Seven Elements of an Effective Compliance Program

Dec 7, 2023•—

Episode 61 – Drug Pricing: New OIG Guidance Reaffirms the Seven Elements of an Effective Compliance Program

Episode 62 – Has FDA Meaningfully Changed Its Restrictions on Off-Label Communications?

Dec 13, 2023•—

Episode 62 – Has FDA Meaningfully Changed Its Restrictions on Off-Label Communications?

Episode 63 – M&A Views: How Should Deal Teams Navigate a Global Crackdown on Restrictive Covenants?

Dec 14, 2023•—

Episode 63 – M&A Views: How Should Deal Teams Navigate a Global Crackdown on Restrictive Covenants?

Episode 64 – Energy & Infrastructure: How Can Companies Avoid Greenwashing Allegations and ESG Litigation Risks?

Dec 17, 2023•—

Episode 64 – Energy & Infrastructure: How Can Companies Avoid Greenwashing Allegations and ESG Litigation Risks?

Episode 65 – PE Views: How Can PE Sponsors Promote Transparency and Successful Fund Raise Amid ESG Scrutiny?

Dec 20, 2023•—

Episode 65 – PE Views: How Can PE Sponsors Promote Transparency and Successful Fund Raise Amid ESG Scrutiny?

Episode 66 – UK FinReg Focus Areas in 2024: Primary Markets Reform

Jan 19, 2024•—

Episode 66 – UK FinReg Focus Areas in 2024: Primary Markets Reform

Episode 67 – PE Views: The Most Pressing Cybersecurity Considerations For Private Equity

Jan 23, 2024•—

Episode 67 – PE Views: The Most Pressing Cybersecurity Considerations For Private Equity

Episode 68 – Drug Pricing: Will Agencies Exercise March-In Rights Based on Drug Price?

Jan 25, 2024•—

Episode 68 – Drug Pricing: Will Agencies Exercise March-In Rights Based on Drug Price?

Episode 69 – UK FinReg Focus Areas in 2024: Retail Markets – Direction of Travel

Jan 26, 2024•—

Episode 69 – UK FinReg Focus Areas in 2024: Retail Markets – Direction of Travel

Episode 70 – UK FinReg Focus Areas in 2024: Investment Research

Jan 31, 2024•—

Episode 70 – UK FinReg Focus Areas in 2024: Investment Research

Episode 71 – Drug Pricing: A Look Ahead at Trends for 2024

Feb 1, 2024•—

Episode 71 – Drug Pricing: A Look Ahead at Trends for 2024

Episode 72 – UK FinReg Focus Areas in 2024: The Edinburgh Reforms

Feb 2, 2024•—

Episode 72 – UK FinReg Focus Areas in 2024: The Edinburgh Reforms

Episode 73 – UK FinReg Focus Areas in 2024: Artificial Intelligence

Feb 8, 2024•—

Episode 73 – UK FinReg Focus Areas in 2024: Artificial Intelligence

Episode 74 – UK FinReg Focus Areas in 2024: Conduct and Culture

Feb 19, 2024•—

Episode 74 – UK FinReg Focus Areas in 2024: Conduct and Culture

Episode 75 – UK FinReg Focus Areas in 2024: Enforcement Against Firms

Feb 23, 2024•—

Episode 75 – UK FinReg Focus Areas in 2024: Enforcement Against Firms

Episode 76 – UK FinReg Focus Areas in 2024: Regulatory Divergence

Feb 29, 2024•—

Episode 76 – UK FinReg Focus Areas in 2024: Regulatory Divergence

Episode 77 – UK FinReg Focus Areas in 2024: Enforcement Against Individuals

Mar 5, 2024•—

Episode 77 – UK FinReg Focus Areas in 2024: Enforcement Against Individuals

Episode 78 – UK FinReg Focus Areas in 2024: ESG

Mar 8, 2024•—

Episode 78 – UK FinReg Focus Areas in 2024: ESG

Episode 79 – Pro Bono: Rewilding the Scottish Highlands Through Forest Restoration

Apr 16, 2024•—

Episode 79 – Pro Bono: Rewilding the Scottish Highlands Through Forest Restoration

Episode 80 – Energy & Infrastructure: Why is Energy Tech So Attractive to Venture Capital?

Jun 10, 2024•—

Episode 80 – Energy & Infrastructure: Why is Energy Tech So Attractive to Venture Capital?

Episode 81 – Drug Pricing: A Look Behind the Curtain of the New ASP Reporting Website and Other Data Collection Portals

Jun 13, 2024•—

Episode 81 – Drug Pricing: A Look Behind the Curtain of the New ASP Reporting Website and Other Data Collection Portals

Episode 82 – Drug Pricing: Takeaways from the New Orleans Pricing and Contracting USA Conference

Jun 21, 2024•—

Episode 82 – Drug Pricing: Takeaways from the New Orleans Pricing and Contracting USA Conference

Episode 83 – Drug Pricing: How Are Payers Responding to the IRA?

Aug 19, 2024•—

Episode 83 – Drug Pricing: How Are Payers Responding to the IRA?

Episode 84 – Pro Bono: Shabir Kabiri's Remarkable Journey from Afghanistan to Asylum in the US

Aug 20, 2024•—

Episode 84 – Pro Bono: Shabir Kabiri's Remarkable Journey from Afghanistan to Asylum in the US

Episode 85 – Drug Pricing: How The Demise of Chevron Deference and Other Litigation May Impact the Pharmaceutical Industry

Sep 18, 2024•—

Episode 85 – Drug Pricing: How The Demise of Chevron Deference and Other Litigation May Impact the Pharmaceutical Industry

Episode 86 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit

Oct 18, 2024•—

Episode 86 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit

Episode 87 – Drug Pricing: What's In the New CMS Medicaid Final Rule?

Nov 25, 2024•—

Episode 87 – Drug Pricing: What's In the New CMS Medicaid Final Rule?

Episode 88 – Drug Pricing: How Might the Trump Administration Transform FDA Enforcement Activities?

Dec 16, 2024•—

Episode 88 – Drug Pricing: How Might the Trump Administration Transform FDA Enforcement Activities?

Episode 89 – The Growth Rocketship: How BridgeBio's Hub and Spoke Portfolio Strategy Set the Market for the Future of Biotech – Then, Now, and What's Next?

Dec 30, 2024•—

Episode 89 – The Growth Rocketship: How BridgeBio's Hub and Spoke Portfolio Strategy Set the Market for the Future of Biotech – Then, Now, and What's Next?

Episode 90 – UK FinReg Focus Areas in 2025: Wholesale Markets

Jan 6, 2025•—

Episode 90 – UK FinReg Focus Areas in 2025: Wholesale Markets

Episode 91 – UK FinReg Focus Areas in 2025: Retail Markets

Jan 6, 2025•—

Episode 91 – UK FinReg Focus Areas in 2025: Retail Markets

Episode 92 – UK FinReg Focus Areas in 2025: Sectoral Trends

Jan 6, 2025•—

Episode 92 – UK FinReg Focus Areas in 2025: Sectoral Trends

Episode 93 – EU's Digital Operational Resilience Act: What You Should Know and How to Stay Compliant

Jan 16, 2025•—

Episode 93 – EU's Digital Operational Resilience Act: What You Should Know and How to Stay Compliant

Episode 94 – Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook

Feb 25, 2025•—

Episode 94 – Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook

Episode 95 – Drug Pricing: FDA in the Age of Executive Orders and DOGE

Mar 12, 2025•—

Episode 95 – Drug Pricing: FDA in the Age of Executive Orders and DOGE

Episode 96 – The Growth Rocketship: Shield AI's Takeoff Shows What's Possible in Defensetech

Apr 30, 2025•—

Episode 96 – The Growth Rocketship: Shield AI's Takeoff Shows What's Possible in Defensetech

Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation

May 2, 2025•—

Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation

Episode 98 – Drug Pricing: Takeaways from the MDMA Annual Meeting

Jun 6, 2025•—

Episode 98 – Drug Pricing: Takeaways from the MDMA Annual Meeting

Episode 99 – Drug Pricing: Takeaways from the Philadelphia Pricing and Contracting USA Conference

Jun 24, 2025•—

Episode 99 – Drug Pricing: Takeaways from the Philadelphia Pricing and Contracting USA Conference

Episode 100 – The Leeds Reforms: Implications for UK Financial Services

Jul 17, 2025•—

Episode 100 – The Leeds Reforms: Implications for UK Financial Services

Episode 101 – EU Data Act: Implications for Data Privacy and Cybersecurity

Sep 10, 2025•—

Episode 101 – EU Data Act: Implications for Data Privacy and Cybersecurity

Episode 102 – EU Data Act: Spotlight on Switching Requirements for Data Processing Services

Sep 11, 2025•—

Episode 102 – EU Data Act: Spotlight on Switching Requirements for Data Processing Services

Episode 103 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit

Oct 2, 2025•—

Episode 103 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit

Episode 104 – Drug Pricing and Market Access: Deep Dive on the FDA Commissioner's National Priority Voucher Program Awards

Nov 3, 2025•—

Episode 104 – Drug Pricing and Market Access: Deep Dive on the FDA Commissioner's National Priority Voucher Program Awards

Episode 105 – Drug Pricing and Market Access: Government Pricing Assessment Expectations and Benefits

Nov 24, 2025•—

Episode 105 – Drug Pricing and Market Access: Government Pricing Assessment Expectations and Benefits

Episode 106 – The FDA's New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway

Dec 15, 2025•—

Episode 106 – The FDA's New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway

Episode 107 – Drug Pricing and Market Access: "Think of It as a Loop" — Succeeding in an Evolving Policy Landscape

Dec 16, 2025•—

Episode 107 – Drug Pricing and Market Access: "Think of It as a Loop" — Succeeding in an Evolving Policy Landscape

You May Also Like

OndaCast© 2026 OndaCast. All rights reserved.

Help Contact Terms Privacy Copyright DMCA About Radio Guide Embed Player

Waves Explore Library Vibes Podcasts Audiobooks